newsfilter
← Latest News
GlobeNewswire·

Trevena Reports Fourth Quarter 2022 Results and Provides Business Update

Company announces initial topline OLINVYK data including GI and cognitive outcomes, and length of stay data from ~200 patient real-world clinical outcomes study TRV045, a novel S1P receptor modulator, continues to